NIH-funded research U01 cooperative agreement

Endoscopic treatment vs shunt for hydrocephalus in infants

Official title: Endoscopic versus Shunt Treatment of Hydrocephalus in Infants

Funded at Utah State Higher Education System--University of Utah · NIH-11411186 · Data updated 2026-11-12

This study compares two treatments for hydrocephalus in babies to see if a shunt-free approach can work as well as the traditional shunt option.

More Hydrocephalus research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2027
Funding year2026
Award (this year)$985,459
NIH project number5U01NS107486-07
Project IDNIH-11411186 on NIH RePORTER

Who could benefit from this research

Could help

Infants ≤12 months corrected age with hydrocephalus treated at participating tertiary pediatric neurosurgery centers in North America.

Less likely to help

Infants not eligible for ETV+CPC or whose condition requires shunt, or whose cognitive outcomes do not align with the non-inferiority criteria, may not benefit.

What this research studies

In infants under one year with hydrocephalus, doctors want to know whether endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) can match the cognitive outcomes of the standard shunt treatment after 12 months. The study will be conducted at major pediatric neurosurgery centers across North America and will use Bayley scales to measure infant cognitive development. It is designed as a non-inferiority trial to see if ETV+CPC offers similar benefits without sacrificing brain development. Families who are open to shunt-free options and understand the risks may consider participating if their infant meets criteria.

Why it matters

Potential benefit: If successful, infants could have a viable shunt-free treatment option that preserves cognitive development and reduces long-term shunt-related complications.

How similar studies have gone: Previous data suggest ETV+CPC can be safe and viable, but cognitive outcomes relative to shunt are not yet established.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Kestle, John — Utah State Higher Education System--University of Utah
  • Study coordinator: Kestle, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.